vimarsana.com

Page 2 - நிறுவனம் அல்லது அல்ஜெர்னான் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Algernon Pharmaceuticals Appoints VP Research & Operations and Chief Medical Officer

Share: VANCOUVER, British Columbia, March 01, 2021 (GLOBE NEWSWIRE) Algernon Pharmaceuticals Inc. (CSE:AGN) (FRANKFURT: AGW) (OTCQB:AGNPF) (the Company or Algernon ) a clinical stage pharmaceutical development company is pleased to announce that it has appointed Dr. Christopher Bryan PhD as Vice President, Research & Operations and Dr. Ahmad Khalil MD, PhD as the Company s Chief Medical Officer. Dr. Christopher Bryan graduated from the University of Toronto, with a PhD in organic chemistry and brings significant skills and experience to Algernon. His background as a scientist and senior manager includes the synthesis of hundreds of novel small molecules as potential therapeutic agents, the coordination of regional commercial teams and internal departments (i.e., marketing, R&D, manufacturing, sales and regulatory affairs), and the management of multiple strategic relationships including those involving key opinion leaders. He also has extensive experience in scientific wri

Algernon Pharmaceuticals Awards DMT Manufacturing Contract to Dalton Pharma for Stroke Program

Buzz on the Street Show: Algernon Pharmaceuticals (OTCQB: AGNPF) (CSE: AGN) Lung Scarring Study | Buzz on the Street Show: Algernon Pharmaceuticals (OTCQB: AGNPF) (CSE: AGN) Lung Scarring StudyFinancial Buzz

Sponsored Content Release FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications. Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on http://www.Fina

Breaking News: Algernon Pharmaceuticals Considers Adding Lung Scarring as an Additional Endpoint for its Phase 2b/3 COVID-19 Study Protocol | Breaking News: Algernon Pharmaceuticals Considers Adding Lung Scarring as an Additional Endpoint for its Phase 2b/3 COVID-19 Study ProtocolFinancial Buzz

Sponsored Content Release FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications. Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on http://www.Fina

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.